ONCI CEO says "BIG M&A NEWS tomorrow> ON4 COMMU
Post# of 98059
ON4 COMMUNICATIONS TO MEET WITH BMW AT ITS CORPORATE HEADQUARTERS IN MUNICH GERMANY ON SEPTEMBER 15 2017
Alert
New York, New York--(Marketwired June 26 2017 On4 Communications, Inc. (OTC Pink: (OTC :ONCI)) - On4 Communications (OTC: ONCI) today announced it will meet with BMW on September 15 2017 at its Corporate Headquarters in Munich Germany.
CEO Steve Berman states, This will be the first of many meetings with the European auto makers. Distracted driving has become an epidemic worldwide. BMW a pioneer in car safety understands that they need to protect consumers in everyway while driving one of their Automobiles.
As previously stated I will be in Europe the week of September 7 to meet with our App designers to finalize the beta testing of our 5 new Apps which will reach the market by 4th quarter 2017. The 5 new apps will be varied. 2 will be in Auto safety, 2 will be in the Sports Gaming industry and 1 will be MJ related. These new Apps will fall under the FMS division of Hexagon Holdings Corporation and will create 5 new streams of revenues for Hexagon Holdings Corp. We have been working on these new apps for the last year and I am pleased to say we are finally there.
Please continue to check with Colorado Secretary of State on Hexagon Holdings Corp as we have filed, and are waiting on the official stamp. That stamp will allow us to file with FINRA expected by tomorrow.
Today I am meeting with Chrysler at 3 pm and will update ASAP.
Stay Tuned tomorrow regarding big M&A news. CEO Steve Berman Concludes..
AboutOn4 Communications
On4 is a holdings company with an aggressive focus of acquiring proven and profitable businesses. Our first project is focusing on businesses operating in the $1.7 trillion U.S. healthcare industry. Our newest targeted businesses are operating in thetrillion-dollarmobile App space. Our first acquisition in the mobile App space is FMS Marketing a global creator and distributor of mobile Apps for Android andIphones. We are also targeting businesses to acquire and joint venture with in the medical marijuana and emerging MJ ancillary products space.